TOWA PHARMACEUTICAL CO.,LTD. [4553.T]
TOKYO, May 14 (Pulse News Wire) – Towa Pharmaceutical Co., Ltd. (4553.T) reported consolidated results for fiscal year 2026 ending March.
Revenue was ¥270 billion (+5.4% YoY). operating profit was ¥23,102 million (-0.6%). net profit attributable to shareholders was ¥5,250 million (-72.3%).
Total assets stood at ¥480 billion with an equity ratio of 37.5%. The company declared an annual dividend of ¥40 per share. The full-year forecast for the current fiscal year is revenue of ¥300 billion (+11.1%).
Financial results — FY2026/3 (consolidated)
| Metric | Current | YoY |
|---|---|---|
| Revenue | ¥273,710M | +5.4% |
| Operating profit | ¥23,102M | -0.6% |
| Net profit | ¥5,250M | -72.3% |
Next period forecast
Revenue
¥304,000M
+11.1%Op. profit
¥32,000M
+38.5%Net profit
¥21,500M
+309.5%Source: TDNet filing · Figures in millions of yen
🟢 Confidence: High AI-translated content.